Weekly measurement of HMGB1 during neoadjuvant chemoradiotherapy in rectal cancer patients: correlations with MRI response and ctDNA
Authors
Franziska Eckert
Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany
Department of Radiation Oncology, Medical University Vienna, CCC Vienna, Vienna, Austria
Vlatko Potkrajcic
Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany
Department of Radiation Oncology, Medical University Vienna, CCC Vienna, Vienna, Austria
Stephan Clasen
Department of Diagnostic and Interventional Radiology, District Hospital Reutlingen, Reutlingen, Germany
Elgin Hoffmann
Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany
Julian Taugner
Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany
Olga Seibel-Kelemen
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany
Christopher Schroeder
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany
Maximilian Niyazi
Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany
Kerstin Clasen
kerstin.clasen@med.uni-tuebingen.de
Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany
RadioChirurgicum, CyberKnife Südwest, Göppingen, Germany
Language: English
Page range: 294 - 300
Submitted on: Feb 24, 2026
Accepted on: May 7, 2026
Published on: Jun 26, 2026
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Franziska Eckert, Vlatko Potkrajcic, Stephan Clasen, Elgin Hoffmann, Julian Taugner, Olga Seibel-Kelemen, Christopher Schroeder, Maximilian Niyazi, Kerstin Clasen, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.